Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
12.00
+0.03 (0.25%)
At close: Dec 24, 2024, 1:00 PM
11.66
-0.34 (-2.83%)
After-hours: Dec 24, 2024, 2:42 PM EST
Roivant Sciences Employees
Roivant Sciences had 908 employees as of March 31, 2024. The number of employees increased by 4 or 0.44% compared to the previous year.
Employees
908
Change (1Y)
4
Growth (1Y)
0.44%
Revenue / Employee
$142,213
Profits / Employee
$5,297,557
Market Cap
8.74B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 908 | 4 | 0.44% |
| Mar 31, 2023 | 904 | 41 | 4.75% |
| Mar 31, 2022 | 863 | 198 | 29.77% |
| Jun 30, 2021 | 665 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Walgreens Boots Alliance | 331,000 |
| Henry Schein | 25,000 |
| Teleflex | 14,500 |
| Bruker | 9,707 |
| Bio-Rad Laboratories | 8,030 |
| Masimo | 3,800 |
| HealthEquity | 3,150 |
| Glaukos | 907 |
ROIV News
- 20 days ago - Roivant Sciences: A Biotech Growth Play With Major Ambitions - Seeking Alpha
- 22 days ago - Roivant's lung disease drug fails mid-stage trial - Reuters
- 6 weeks ago - Roivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 2 months ago - Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility - Seeking Alpha
- 3 months ago - Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B - Benzinga
- 3 months ago - Roivant Flips a Skin Drug to Organon - Barrons
- 3 months ago - Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - Business Wire